United Launch Alliance Will Use CDI’s DSPCon Test and Measurement Solutions for Mission-Critical Tests on Orion’s Launch Systems CDI Corp. (NYSE: CDI) announced today that its DSPCon subsidiary has ...
Best practices of nucleic acid amplification tests for the diagnosis of clostridioides (clostridium)
A new review looks at the challenges of testing for Clostridioides (Clostridium) difficile infection (CDI) and recommendations for newer diagnostic tests. Accurate diagnosis of CDI is critical for ...
Clostridium bacteria, computer illustration. Clostridia are spore-forming bacteria that include several human pathogenic species, C. difficile, C. tetani, C. botulinum, C. perfringens, and others. C.
Simply adding an admission screening question and a 2-step testing algorithm sharply decreased the number of Clostridioides difficile infections (CDI) in the year after implementing the interventions.
Mobidiag Ltd has announced the launch of Amplidiag™ C. difficile+027, a qualitative qPCR-based test performed from DNA extracted from stool in suspected cases of C. difficile infection (CDI). The test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback